Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

212.06 -1.53 (-0.72%)
Official Closing Price Updated: 7:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,139,790
Open 212.00
Bid (Size) 211.21 (3)
Ask (Size) 213.70 (1)
Prev. Close 213.59
Today's Range 209.31 - 213.87
52wk Range 153.58 - 218.66
Shares Outstanding N/A
Dividend Yield 2.92%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion
The company is looking to test a combination of the drug it acquired from Carmot Therapeutics and a amylin-based drug. 
Via Investor's Business Daily
Worried About a Market Meltdown? 2 Dividend Stocks to Own Forever.
Via The Motley Fool

Performance

YTD
+18.18%
+18.18%
1 Month
+11.41%
+11.41%
3 Month
+21.61%
+21.61%
6 Month
+8.98%
+8.98%
1 Year
+17.21%
+17.21%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Vanguard High Dividend Yield ETF vs Vanguard Dividend Appreciation ETF: Which Is Best for You?
Via The Motley Fool
Topics ETFs
AbbVie Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
13 Analysts Have This To Say About AbbVie
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Via Benzinga
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Mixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas
Via The Motley Fool
This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy?
Via The Motley Fool
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week
Via Stocktwits
3 Stocks Breaking Out Right Now
Via Talk Markets
Topics Stocks / Equities
Is the SPDR S&P 500 ETF Trust the Smartest Investment You Can Make Today?
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
3 Cheap Stocks to Buy With Your Tax Refund Check
Via The Motley Fool
2 Dividend Stocks to Buy for a Lifetime of Passive Income
Via The Motley Fool
Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
AbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race
Via Benzinga
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
Via Investor's Business Daily
These Vanguard ETFs Show Where the Smart Money Is Moving Now
Via The Motley Fool
Topics ETFs
4 Sectors That Thrive When Inflation Runs Hot
Via MarketBeat
Topics Economy World Trade
Exposures Interest Rates Tariff
3 Reasons ABBV is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Via The Motley Fool
2 High-Yield Dividend ETFs to Buy to Generate Passive Income
Via The Motley Fool
Topics ETFs
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS